Introduction

Opioid use disorder (OUD) is a chronic, relapsing medical disease. In correctional settings, it is also a predictable driver of withdrawal, destabilization, preventable overdose, and avoidable re-incarceration. The clinical reality is straightforward: medications for opioid use disorder (MOUD) including buprenorphine/naloxone (Suboxone) reduce cravings, reduce illicit opioid use, and reduce death risk when people return to the community. Withholding MOUD is not “tough love.” It is a systems-level choice that increases medical risk.

Close to two-thirds of people in jail meet criteria for a substance use disorder, and OUD is common in that population.In the weeks after release, overdose risk rises sharply because tolerance drops during incarceration; classic cohort data show an extreme overdose-mortality spike in the first two weeks after release. 

DevotedDOc was built specifically for this high-risk window before, during, and after custody using a physician-led model, clinical informatics infrastructure, and a growing justice-health leadership team.

Current State of MOUD in Jails & Prisons

Despite clear evidence, MOUD availability remains inconsistent across the U.S. Some systems have expanded access meaningfully; many still do not offer MOUD at scale. National utilization data show a dramatic increase in buprenorphine use in jails/prisons from 2016–2021 an important signal that policy and practice are shifting but it is not yet a universal implementation. 

Pew and national correctional health groups have repeatedly emphasized that access gaps are often driven by funding mechanics, staffing constraints, operational complexity, stigma, and misconceptions about “replacing one substance with another.”

Why Suboxone (Buprenorphine/Naloxone) Matters During Incarceration

1) Stabilization is a safety intervention, not a luxury

Untreated opioid withdrawal is not benign. It drives insomnia, autonomic instability, agitation, and medical decompensation especially when combined with co-occurring psychiatric illness, stimulant use, alcohol use, hepatitis C, and HIV. In custody, destabilization increases the risk of self-harm and use of contraband substances.

2) MOUD reduces overdose risk after release

Post-release overdose risk is highest early, when tolerance has dropped and return-to-use is common. Multiple public health summaries emphasize this “high-risk re-entry” period and the measurable benefit of keeping patients on MOUD through transitions.

3) MOUD supports engagement and reduces cycling through the system

People who leave custody stabilized are more likely to attend follow-up care, adhere to treatment plans, and avoid the relapse–rearrest loop. This is a clinical continuity problem and also a systems-cost problem.

Common Arguments Against MOUD in Facilities and the Clinical Reality

“It’s just replacing one addiction with another.”

This is the most common misconception. Dependence (expected physiologic adaptation) is not the same as addiction (compulsive use despite harm). MOUD is evidence-based treatment endorsed broadly across medicine and public health because it reduces death and improves function. 

“Diversion will increase.”

Diversion risk is real in correctional settings, but it is manageable with proper workflows: observed dosing where appropriate, reasonable formulation selection, chain-of-custody controls, clinical monitoring, and clear policies. Eliminating MOUD entirely is a blunt response that punishes medically appropriate patients.

“We don’t have the staffing or process.”

This is an operations problem, not a medical argument. The most successful correctional MOUD programs are built like high-reliability systems: standardized intake screening, rapid initiation pathways, consistent follow-up cadence, and tight re-entry handoffs.

The Future of MOUD in Corrections: Where the Trend Is Going

The direction is clear: more correctional systems are adopting MOUD, and national data show rapidly rising buprenorphine utilization in jails and prisons over recent years.  Courts, policymakers, and correctional health leaders are increasingly treating MOUD as medically necessary care rather than an optional service line.

What DevotedDOc Is Doing Differently: A Physician-Led Justice-Health Model

DevotedDOc is a physician-led organization designed for high-risk, underserved, and justice-involved populations, built by emergency physicians, toxicologists, addiction specialists, and clinical informatics experts. We operate with a “continuity-first” approach that treats incarceration and re-entry as a clinical transition similar to hospital discharge, but with much higher overdose risk.

Clinical governance and specialty oversight

Our justice-health programs are overseen with regional clinical leadership and a governance structure designed for guideline-based MOUD and coordinated care.

“Florida 72-Hour Bridge” transition-of-care model

DevotedDOc’s Florida re-entry strategy emphasizes rapid continuity medication access and a clinical visit within the earliest post-release window because that is where preventable deaths happen. 

Infrastructure that scales beyond one state

We are building cross-state operational playbooks and partner networks that can support justice-involved patients in Florida, Georgia, New Mexico, and Oklahoma including referral workflows, pharmacy-ready discharge coordination, and telehealth continuity when geography is a barrier.

Practical Implementation: What High-Performing Jail/Prison MOUD Programs Include

If you are a sheriff, jail administrator, public health leader, or community partner, the operational best practices are consistent:

• Universal screening at intake (OUD history, prior MOUD, overdose history, co-occurring alcohol/benzo risk)
  
• Rapid initiation or continuation protocols for buprenorphine
  
• Diversion controls that are clinically respectful and operationally enforceable
  
• Re-entry medication continuity (appointments scheduled before release, pharmacy coordination, warm handoff)
  
• Measurement (first-fill success, 7/30/90-day retention, ED utilization, overdoses, re-incarceration signals)
  

National correctional health and policy organizations have published toolkits and implementation guidance aligned with these principles.

A Note to Families: Why “Starting Now” Matters

If your loved one is justice-involved or at risk of becoming justice-involved waiting for a crisis is the most dangerous plan. Establishing care early improves continuity and reduces the likelihood of abrupt withdrawal, relapse, and overdose. If someone is ready for treatment, the best time to act is while motivation is present and access is available.

Call to Action: Partner or Refer

For organizations: DevotedDOc partners with correctional systems, courts, and public health groups to deliver physician-led MOUD and continuity of care.

For families: Support treatment access through DevotedDOc’s donation pathway:
https://devoteddoc.com/donate/

Medically Reviewed By:

— The DevotedDOc Founder | Emergency Physician | Advocate for Patients and Clinician-Led Virtual Care